<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02877433</url>
  </required_header>
  <id_info>
    <org_study_id>CR 03/15</org_study_id>
    <nct_id>NCT02877433</nct_id>
  </id_info>
  <brief_title>4 mm Implants in Fixed Cross-Arch Prostheses</brief_title>
  <official_title>Clinical Performance of 4 mm Short Distal Implants in Fixed Cross-Arch Prostheses - An Open, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Straumann AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Straumann AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the clinical performance of 4 mm short implants supporting
      cross-arch fixed reconstructions in the edentulous mandible either with a combination of two
      short implants as distal support and two implants of conventional length placed in the
      interforaminal region, or with a combination of four short implants as distal support and two
      interforaminal implants of conventional length.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a post-market, multi-center, prospective, open, randomized controlled clinical study.
      The total study duration for each patient should be 36 ± 2 months.

      Roxolid Standard Plus Implants, 4 mm, Ø 4.1 mm, SLActive will be placed in positions 36/46 or
      35/45, 36/46.

      Roxolid Standard Plus Implants, Ø 4.1 mm, SLActive, in lengths of 10, 12 and 14 mm will be
      placed in positions 33/43.

      In total 10 visits per patient are scheduled in this study. Implant survival, implant
      success, prosthetic survival and success, and adverse events (AEs) will be assessed.

      All products are CE-(Conformité Européenne, meaning European Conformity) marked and used
      within its intended use.

      Two centers in Switzerland and Northern Ireland will participate. The study and any
      amendments will be performed according to International Organization for Standardization
      (ISO) 14155:2011, local legal and regulatory requirements and conform to the Declaration of
      Helsinki (last revision Fortaleza 2013)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant survival</measure>
    <time_frame>12 months after baseline</time_frame>
    <description>A surviving implant is defined as an implant in place at the time of the follow-up. Any implant loss shall be assessed as an early loss (implant fails before being osseointegrated) or late loss (after being osseointegrated)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implant success will be evaluated according to Buser</measure>
    <time_frame>12 and 36 months after baseline</time_frame>
    <description>A particular implant will be considered successful if all of the following success criteria according to Buser et al. (Buser et al. 1991) apply:
Absence of persisting subjective discomfort such as pain, foreign body perception and or dysaesthesia (painful sensation)
Absence of a recurrent peri-implant infection with suppuration (where an infection is termed recurrent if observed at two or more follow-up visits after the treatment with systemic antibiotics)
Absence of implant mobility on manual palpation
Absence of any continuous peri-implant radiolucency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic survival &amp; success</measure>
    <time_frame>12 and 36 months after baseline</time_frame>
    <description>During the prosthodontic examination, the implant supported prostheses will be examined for any complications and failures as adapted from the ITI Treatment Guide Volume 8 (Brägger &amp; Heitz-Mayfield 2015)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Crestal bone level change at the implant site (mesial and distal)</measure>
    <time_frame>12 and 36 months after baseline</time_frame>
    <description>Mesial and distal implant bone levels will be evaluated on a panoramic radiograph at baseline, 12 and 36 months after implant loading</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Implant survival</measure>
    <time_frame>36 months after baseline</time_frame>
    <description>A surviving implant is defined as an implant in place at the time of the follow-up. Any implant loss shall be assessed as an early loss (implant fails before being osseointegrated) or late loss (after being osseointegrated)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Jaw Edentulous</condition>
  <arm_group>
    <arm_group_label>Roxolid short implant, 4 mm length (4)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Straumann Tissue Level Ø4.1 mm RN SLActive Roxolid Standard Plus Implants available in lengths 4mm, 10mm, 12mm and 14mm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Roxolid short implant, 4 mm length (2)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Straumann Tissue Level Ø4.1 mm RN SLActive Roxolid Standard Plus Implants available in lengths 4mm, 10mm, 12mm and 14mm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Roxolid short implant, 4 mm length (4)</intervention_name>
    <description>Placement of a combination of four short implants (in positions 35/45, 36/46) as distal support and two implants of conventional length (in positions 33/43) in the interforaminal region, in order to support a cross-arch fixed screw-retained prosthesis.</description>
    <arm_group_label>Roxolid short implant, 4 mm length (4)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Roxolid short implant, 4 mm length (2)</intervention_name>
    <description>Placement of a combination of two short implants (in positions 36/46) as distal support and two implants of conventional length (in positions 33/43) in the interforaminal region, in order to support a cross-arch fixed screw-retained prosthesis.</description>
    <arm_group_label>Roxolid short implant, 4 mm length (2)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females with at least 18 years of age (including 18 years)

          -  Subject must have voluntarily signed the informed consent, are willing and able to
             attend scheduled follow-up visits, and agree that the encoded data will be collected
             and analyzed

          -  Fully edentulous (latest extraction in the mandible should be performed at least 12
             weeks before implant placement) that can be restored with a complete denture

          -  Atrophic jaw bone in the posterior area, sufficient bone height and width to permit
             insertion of four short implants, 4 mm in regions of the first molar and second
             premolar on both sides and two standard length implants in the canine region

        Exclusion Criteria:

          -  Patients with inadequate bone volume and/or quality

          -  Uncontrolled systemic disease that would interfere with dental implant therapy (e.g.
             uncontrolled diabetes)

          -  Any contraindications for oral surgical procedures

          -  History of local irradiation therapy in the head / neck area

          -  Patients who smoke &gt;10 cigarettes per day or tobacco equivalents, chew tobacco or have
             ≥ 20 pack years

          -  Medical conditions requiring chronic high dose steroid therapy or high dose
             anti-resorptive treatment

          -  Subjects who have undergone administration of any investigational device within 30
             days of enrollment in the study

          -  Conditions or circumstances, in the opinion of the investigator, which would prevent
             completion of study participation or interfere with analysis of study results, such as
             history of non-compliance or unreliability

          -  Cognitive impairment that would interfere with the ability to perform adequate oral
             hygiene (assessed by the Ottawa 3DY scale)

          -  Patients with chronic pain

          -  Patients with HIV and/ or Hepatitis infection

          -  Severe bruxing or clenching habits

          -  Patients with inadequate oral hygiene or unmotivated for adequate home care (Denture
             Plaque Index (DPI) ≥ 5)

          -  Patients with drug or alcohol abuse

          -  Patients with allergies or hypersensitivity to chemical ingredients of
             titanium-zirconium alloy

          -  Major simultaneous augmentation procedures. Dehiscence of a vertical distance of more
             than 3 mm

          -  A woman who is pregnant or planning to become pregnant at any point during the study
             duration

        Secondary Exclusion Criteria:

          -  Patients with inadequate bone volume and/or quality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia-Gabriela Wittneben, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern, Department of Reconstructive Dentistry and Gerodontology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica Becaud, PhD</last_name>
    <phone>+41 61 965 15 36</phone>
    <email>jessica.becaud@straumann.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Bern, Department of Reconstructive Dentistry and Gerodontology</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia-Gabriela Wittneben, Dr.</last_name>
      <phone>+41 77 46 310 03</phone>
      <email>julia.wittneben@zmk.unibe.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queens University Belfast, School of Medecine, Dentistry and Biomedical Sciences</name>
      <address>
        <city>Belfast</city>
        <zip>BT9 7BL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerry McKenna, Dr.</last_name>
      <phone>+44 28 909 789 99</phone>
      <email>g.mckenna@qub.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Albrektsson T, Zarb GA. Current interpretations of the osseointegrated response: clinical significance. Int J Prosthodont. 1993 Mar-Apr;6(2):95-105. Review.</citation>
    <PMID>8329101</PMID>
  </reference>
  <reference>
    <citation>Allen F, Locker D. A modified short version of the oral health impact profile for assessing health-related quality of life in edentulous adults. Int J Prosthodont. 2002 Sep-Oct;15(5):446-50.</citation>
    <PMID>12375458</PMID>
  </reference>
  <reference>
    <citation>Ambjørnsen E, Valderhaug J, Norheim PW, Fløystrand F. Assessment of an additive index for plaque accumulation on complete maxillary dentures. Acta Odontol Scand. 1982;40(4):203-8.</citation>
    <PMID>6958165</PMID>
  </reference>
  <reference>
    <citation>Annibali S, Cristalli MP, Dell'Aquila D, Bignozzi I, La Monaca G, Pilloni A. Short dental implants: a systematic review. J Dent Res. 2012 Jan;91(1):25-32. doi: 10.1177/0022034511425675. Epub 2011 Oct 27. Review.</citation>
    <PMID>22034499</PMID>
  </reference>
  <reference>
    <citation>Benzing U, Weber H, Simonis A, Engel E. Changes in chewing patterns after implantation in the edentulous mandible. Int J Oral Maxillofac Implants. 1994 Mar-Apr;9(2):207-13.</citation>
    <PMID>8206557</PMID>
  </reference>
  <reference>
    <citation>Brennan M, Houston F, O'Sullivan M, O'Connell B. Patient satisfaction and oral health-related quality of life outcomes of implant overdentures and fixed complete dentures. Int J Oral Maxillofac Implants. 2010 Jul-Aug;25(4):791-800.</citation>
    <PMID>20657876</PMID>
  </reference>
  <reference>
    <citation>Buser D, Weber HP, Bragger U, Balsiger C. Tissue integration of one-stage ITI implants: 3-year results of a longitudinal study with Hollow-Cylinder and Hollow-Screw implants. Int J Oral Maxillofac Implants. 1991 Winter;6(4):405-12.</citation>
    <PMID>1820309</PMID>
  </reference>
  <reference>
    <citation>Carlsson GE, Lindquist LW. Ten-year longitudinal study of masticatory function in edentulous patients treated with fixed complete dentures on osseointegrated implants. Int J Prosthodont. 1994 Sep-Oct;7(5):448-53.</citation>
    <PMID>7802913</PMID>
  </reference>
  <reference>
    <citation>de Grandmont P, Feine JS, Taché R, Boudrias P, Donohue WB, Tanguay R, Lund JP. Within-subject comparisons of implant-supported mandibular prostheses: psychometric evaluation. J Dent Res. 1994 May;73(5):1096-104.</citation>
    <PMID>8006237</PMID>
  </reference>
  <reference>
    <citation>Hamdan NM, Gray-Donald K, Awad MA, Johnson-Down L, Wollin S, Feine JS. Do implant overdentures improve dietary intake? A randomized clinical trial. J Dent Res. 2013 Dec;92(12 Suppl):146S-53S. doi: 10.1177/0022034513504948. Epub 2013 Oct 24.</citation>
    <PMID>24158335</PMID>
  </reference>
  <reference>
    <citation>Heydecke G, Locker D, Awad MA, Lund JP, Feine JS. Oral and general health-related quality of life with conventional and implant dentures. Community Dent Oral Epidemiol. 2003 Jun;31(3):161-8.</citation>
    <PMID>12752541</PMID>
  </reference>
  <reference>
    <citation>Ikebe K, Matsuda K, Morii K, Furuya-Yoshinaka M, Nokubi T, Renner RP. Association of masticatory performance with age, posterior occlusal contacts, occlusal force, and salivary flow in older adults. Int J Prosthodont. 2006 Sep-Oct;19(5):475-81.</citation>
    <PMID>17323726</PMID>
  </reference>
  <reference>
    <citation>John MT, Patrick DL, Slade GD. The German version of the Oral Health Impact Profile--translation and psychometric properties. Eur J Oral Sci. 2002 Dec;110(6):425-33.</citation>
    <PMID>12507215</PMID>
  </reference>
  <reference>
    <citation>Millwood J, Heath MR. Food choice by older people: the use of semi-structured interviews with open and closed questions. Gerodontology. 2000 Jul;17(1):25-32.</citation>
    <PMID>11203509</PMID>
  </reference>
  <reference>
    <citation>Mombelli A, van Oosten MA, Schurch E Jr, Land NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987 Dec;2(4):145-51.</citation>
    <PMID>3507627</PMID>
  </reference>
  <reference>
    <citation>Müller F, Duvernay E, Loup A, Vazquez L, Herrmann FR, Schimmel M. Implant-supported mandibular overdentures in very old adults: a randomized controlled trial. J Dent Res. 2013 Dec;92(12 Suppl):154S-60S. doi: 10.1177/0022034513509630. Epub 2013 Oct 24.</citation>
    <PMID>24158342</PMID>
  </reference>
  <reference>
    <citation>Müller F, Hernandez M, Grütter L, Aracil-Kessler L, Weingart D, Schimmel M. Masseter muscle thickness, chewing efficiency and bite force in edentulous patients with fixed and removable implant-supported prostheses: a cross-sectional multicenter study. Clin Oral Implants Res. 2012 Feb;23(2):144-150. doi: 10.1111/j.1600-0501.2011.02213.x. Epub 2011 Jun 2.</citation>
    <PMID>21631592</PMID>
  </reference>
  <reference>
    <citation>Rashid F, Awad MA, Thomason JM, Piovano A, Spielberg GP, Scilingo E, Mojon P, Müller F, Spielberg M, Heydecke G, Stoker G, Wismeijer D, Allen F, Feine JS. The effectiveness of 2-implant overdentures - a pragmatic international multicentre study. J Oral Rehabil. 2011 Mar;38(3):176-84. doi: 10.1111/j.1365-2842.2010.02143.x.</citation>
    <PMID>20704639</PMID>
  </reference>
  <reference>
    <citation>Schimmel M, Christou P, Herrmann F, Müller F. A two-colour chewing gum test for masticatory efficiency: development of different assessment methods. J Oral Rehabil. 2007 Sep;34(9):671-8.</citation>
    <PMID>17716266</PMID>
  </reference>
  <reference>
    <citation>Schimmel M, Christou P, Miyazaki H, Halazonetis D, Herrmann FR, Müller F. A novel colourimetric technique to assess chewing function using two-coloured specimens: Validation and application. J Dent. 2015 Aug;43(8):955-64. doi: 10.1016/j.jdent.2015.06.003. Epub 2015 Jun 22.</citation>
    <PMID>26111925</PMID>
  </reference>
  <reference>
    <citation>Sheiham A, Steele JG, Marcenes W, Lowe C, Finch S, Bates CJ, Prentice A, Walls AW. The relationship among dental status, nutrient intake, and nutritional status in older people. J Dent Res. 2001 Feb;80(2):408-13.</citation>
    <PMID>11332523</PMID>
  </reference>
  <reference>
    <citation>Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile. Community Dent Health. 1994 Mar;11(1):3-11.</citation>
    <PMID>8193981</PMID>
  </reference>
  <reference>
    <citation>Slotte C, Grønningsaeter A, Halmøy AM, Öhrnell LO, Mordenfeld A, Isaksson S, Johansson LÅ. Four-Millimeter-Long Posterior-Mandible Implants: 5-Year Outcomes of a Prospective Multicenter Study. Clin Implant Dent Relat Res. 2015 Oct;17 Suppl 2:e385-95. doi: 10.1111/cid.12252. Epub 2014 Jul 17.</citation>
    <PMID>25041489</PMID>
  </reference>
  <reference>
    <citation>Thomason JM, Feine J, Exley C, Moynihan P, Müller F, Naert I, Ellis JS, Barclay C, Butterworth C, Scott B, Lynch C, Stewardson D, Smith P, Welfare R, Hyde P, McAndrew R, Fenlon M, Barclay S, Barker D. Mandibular two implant-supported overdentures as the first choice standard of care for edentulous patients--the York Consensus Statement. Br Dent J. 2009 Aug 22;207(4):185-6. doi: 10.1038/sj.bdj.2009.728.</citation>
    <PMID>19696851</PMID>
  </reference>
  <reference>
    <citation>van der Bilt A. Assessment of mastication with implications for oral rehabilitation: a review. J Oral Rehabil. 2011 Oct;38(10):754-80. doi: 10.1111/j.1365-2842.2010.02197.x. Epub 2011 Jan 17. Review.</citation>
    <PMID>21241351</PMID>
  </reference>
  <reference>
    <citation>van der Bilt A, Burgers M, van Kampen FM, Cune MS. Mandibular implant-supported overdentures and oral function. Clin Oral Implants Res. 2010 Nov;21(11):1209-13. doi: 10.1111/j.1600-0501.2010.01915.x.</citation>
    <PMID>20572834</PMID>
  </reference>
  <reference>
    <citation>van Kampen FM, van der Bilt A, Cune MS, Fontijn-Tekamp FA, Bosman F. Masticatory function with implant-supported overdentures. J Dent Res. 2004 Sep;83(9):708-11.</citation>
    <PMID>15329377</PMID>
  </reference>
  <reference>
    <citation>Woda A, Hennequin M, Peyron MA. Mastication in humans: finding a rationale. J Oral Rehabil. 2011 Oct;38(10):781-4. doi: 10.1111/j.1365-2842.2011.02235.x.</citation>
    <PMID>22093138</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Small diameter implant</keyword>
  <keyword>Cross-arch prostheses</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

